Attached files

file filename
EX-10.1 - EXHIBIT 10.1 - IMMUCOR INCex10-1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 


FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  January 25, 2013

IMMUCOR, INC.
(Exact name of registrant as specified in its charter)
 
 Georgia    0-14820     22-2408354
 (State or other jurisdiction of incorporation)    (Commission File Number)     (IRS Employer Identification No.)
         
 3130 Gateway Drive, Norcross, Georgia     30071
 (Address of principal executive offices)     (Zip Code)
 
Registrant's telephone number, including area code: (770) 441-2051

Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



 
 

 
 
Item 1.01 Entry into a Material Definitive Agreement.
 
On January 25, 2013, Immucor, Inc. (the “Company”), IVD Intermediate Holdings B Inc., the Subsidiary Guarantor party thereto, CitiBank, N.A., as Administrative Agent, and certain other parties thereto modified the Company’s senior secured credit facilities (the “Credit Facilities”) by entering into Amendment No. 2 (the “Amendment”) to the credit agreement among the parties dated as of August 19, 2011 (as amended August 21, 2012).

 The Amendment provides for an additional $50 million of Incremental Term B-1 Loans to finance the previously announced acquisition of the LIFECODES business (the “Acquisition”).  The Amendment will become effective on the date of the closing of the Acquisition (the “Effective Date”).  The Incremental Term B-1 Loans will have the same terms as the existing Term B-1 Loans .  In the event that the Acquisition closes after March 4, 2013, the Company will owe an unused commitment fee to the lenders for the portion of the period from March 4, 2013 to the Effective Date.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 to this current report on Form 8-K.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 is incorporated by reference into this Item 2.03.

Item 9.01 Financial Statements and Exhibits.

10.1
Amendment No. 2 to Amended and Restated Credit Agreement, dated as of August 21, 2012, by and among Immucor, Inc., IVD Intermediate Holdings B Inc., the Subsidiary Guarantor party thereto, CitiBank, N.A., as administrative agent, and certain other parties thereto.

 
 

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
IMMUCOR, INC.
 
       
Date:  January 31, 2013
By:
/s/ Dominique Petitgenet  
   
Dominique Petitgenet
 
    Vice President and Chief Financial Officer